Biolife Solutions Inc Stock
Your prediction
Biolife Solutions Inc Stock
Biolife Solutions Inc gained 0.740% compared to yesterday.
Pros and Cons of Biolife Solutions Inc in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biolife Solutions Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biolife Solutions Inc | 0.740% | 1.481% | 12.295% | 45.745% | 30.476% | 53.933% | -30.948% |
| Pacira Pharmaceuticals | 2.630% | 3.540% | 5.405% | 25.134% | 8.333% | -28.221% | -52.439% |
| Supernus Pharmaceuticals | -2.960% | -1.942% | -0.493% | 39.310% | -6.047% | 46.377% | 83.636% |
| Collegium Pharmaceutical Inc | -0.640% | 1.290% | -0.633% | 18.939% | -24.155% | 58.586% | 52.427% |
News
Repligen Q2 Earnings Call Highlights
Key Points
- Interested in Repligen Corporation? Here are five stocks we like better.
- Strong second-quarter performance: Repligen reported $204 million in revenue, up 12% year over year and 13%
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
Key Points
- Interested in Repligen Corporation? Here are five stocks we like better.
- Repligen is acquiring BioLife Solutions in a deal valued at about $1.5 billion, paying $31 per share in a